Tofacitinib Is an Effective Treatment for Refractory Scleromyositis Associated With Anti-PM/Scl

Scleromyositis is a rare autoimmune disease characterized by overlapping scleroderma and myositis. This case report discusses the presentation and management of a 28-year-old male with scleromyositis presenting with myositis, arthritis, Raynaud’s phenomenon, refractory calcinosis, interstitial lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Álvarez Troncoso, Jorge, Nuño González, Almudena, Martínez Robles, Elena, Sorriguieta Torre, Raquel, Robles Marhuenda, Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947514/
https://www.ncbi.nlm.nih.gov/pubmed/36843820
http://dx.doi.org/10.7759/cureus.34125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947514/
https://www.ncbi.nlm.nih.gov/pubmed/36843820
http://dx.doi.org/10.7759/cureus.34125

Ejemplares similares